Multidisciplinary experts in AAV gene therapy
We connect academia and industry to support AAV gene therapy development from A to Z.
About Trellis
We are the Trellis Research Group, headed by professor Els Henckaerts. Trellis specializes in the development of gene therapies using non-pathogenic adeno-associated virus (AAV) vectors.
Updates from the lab
Bram Vandewinkel published a research article on the adeno-associated virus Rep proteins that target PP4:SMEK1 by preventing substrate recruitment
Published on March 17, 2026
Continue reading
Simon Sinnaeve wrote an article for ONafhankelijk Informatiecentrum over Cochleaire Implantatie titled “Gentherapie: virussen inzetten tegen erfelijk gehoorverlies."
Published on January 20, 2026
Continue reading
Simon Sinnaeve wrote an article for ONafhankelijk Informatiecentrum over Cochleaire Implantatie titled “Gentherapie: virussen inzetten tegen erfelijk gehoorverlies."
Published on January 20, 2026
Continue reading